SUBSCRIBE
SUBSCRIBE

RadioMedix

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
Business
RadioMedix appointed Dr.Ferey Faridian as new member of the Board of Director
October 13, 2020
 · 
2 min read
BioMidwest
ITM and RadioMedix announce Drug Master File Submission for ITM’s 68Ge/68Ga Generator GeGant® for the U.S. Market
July 10, 2020
 · 
6 min read
Business
RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada
February 10, 2020
 · 
4 min read
Drug Development
RadioMedix selected for 2019-2020 NIH SBIR/STTR Commercialization Accelerator Program (CAP)
January 3, 2020
 · 
3 min read
Business
Novigenix and RadioMedix to Develop Neuroendocrine Cancer Precision Diagnostic Test
October 14, 2019
 · 
3 min read
Business
Vect-Horus and RadioMedix Announce Signing of a Letter of Intent to Co-Develop a Radio-Theranostic Agent for Glioblastoma
March 5, 2019
 · 
3 min read
Business
RadioMedix and ITM Announce Agreement for Manufacturing of Ge-68/Ga-68 Generators in U.S.
July 26, 2018
 · 
2 min read
Drug Development
Radiomedix and AREVA Med Announce Initiation of Phase I Clinical Trial of Alphamedix, a Targeted Alpha Therapy for Patients With Neuroendocrine Tumors
January 10, 2018
 · 
4 min read
Business
RadioMedix Selected for National Cancer Institute’s Investor Initiatives and Presentation at BIO Investor Forum
October 17, 2017
 · 
2 min read
Business
Extended Partnership Between RadioMedix And ITM´s Subsidiary ITG For Exclusive Distribution Of N.C.A Lutetium-177 In North America
October 11, 2017
 · 
4 min read
Load More
JOBS